Ledyard National Bank purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 710 shares of the pharmaceutical company’s stock, valued at approximately $250,000. Several other institutional investors and hedge funds […]
Swiss National Bank lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 8.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 930,300 shares of the pharmaceutical company’s stock after selling 88,500 shares during the period. Swiss National Bank […]
Investment House LLC bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 580 shares of the pharmaceutical company’s stock, valued at approximately $204,000. A number of other institutional investors have also added to or […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) issued its quarterly earnings results on Monday. The pharmaceutical company reported $4.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.55 by $0.53, RTT News reports. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.50 billion. Vertex […]
Grandfield & Dodd LLC boosted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,018 shares of the pharmaceutical company’s stock after buying an additional 30 shares during the period. […]